Efficacy and Safety of Wuling San on Breast Cancer-related Lymphedema
Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Wuling San, a traditional
Chinese medicine, in reducing arm volume excess in women with stage I-II breast cancer
related unilateral lymphedema.
Phase:
N/A
Details
Lead Sponsor:
Fourth Affiliated Hospital of Guangxi Medical University
Collaborators:
Liuzhou Hospital of Traditional Chinese Medicine Liuzhou Maternity and Child Healthcare Hospital